首頁 › 紅斑性狼瘡 › 俄克拉荷馬州 › Oklahoma City
Oklahoma City, OK 的 紅斑性狼瘡 臨床試驗
8 項針對 紅斑性狼瘡 的研究正在 Oklahoma City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
招募中3 期
- Sl0044 50262, Oklahoma City
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
招募中2 期
- Oklahoma Medical Research Foundation, Oklahoma City
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
招募中3 期
- Research Site, Oklahoma City
- Research Site, Oklahoma City
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
招募中4 期
- Oklahoma Medical Research Foundation, Oklahoma City
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
招募中觀察性研究
- Oklahoma Medical Research Foundation, Oklahoma City
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
招募中3 期
- Oklahoma Medical Research Foundation, Oklahoma City
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
招募中1 期
- University of Oklahoma, Oklahoma City
Safety of the Herpes Zoster Subunit Vaccine in Lupus
招募中4 期
- Oklahoma Medical Research Foundation, Oklahoma City
其他城市的 紅斑性狼瘡 試驗
- New York City, NY18 項研究
- Houston, TX13 項研究
- Durham, NC12 項研究
- Washington, DC10 項研究
- Miami, FL10 項研究
- Tampa, FL9 項研究
- Philadelphia, PA9 項研究
- Clearwater, FL8 項研究
- Santa Monica, CA8 項研究
- Boston, MA8 項研究
- Los Angeles, CA8 項研究
- Chicago, IL8 項研究
Oklahoma City 的其他研究
- 非小細胞肺癌28 項研究
- 卵巢癌28 項研究
- 子宮內膜癌25 項研究
- 大腸直腸癌22 項研究
- 前列腺癌21 項研究
- 肺癌19 項研究
- 乳癌17 項研究
- 轉移性癌症15 項研究
- 癌症（所有類型）14 項研究
- 急性髓系白血病14 項研究
- 頭頸部鱗狀細胞癌13 項研究
- 胰臟癌11 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。